Neovacs S.A. (EPA:ALNEV)
0.0018
-0.0001 (-5.26%)
Feb 12, 2026, 1:23 PM CET
Neovacs Employees
Neovacs had 16 employees as of June 30, 2025. The number of employees decreased by 4 or -20.00% since the number was reported on December 31, 2024.
Employees
16
Change
-4
Growth
-20.00%
Revenue / Employee
€12,454
Profits / Employee
€272,371
Market Cap
906.00
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 16 | -4 | -20.00% |
| Dec 31, 2024 | 20 | -2 | -9.09% |
| Dec 31, 2023 | 22 | 1 | 4.76% |
| Dec 31, 2022 | 21 | 2 | 10.53% |
| Dec 31, 2021 | 19 | 4 | 26.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IntegraGen | 40 |
| Biophytis | 19 |
| GeNeuro | 17 |
| Plant Advanced Technologies | 16 |
| Oncodesign Precision Medicine Société anonyme | 14 |
| GenSight Biologics | 13 |
| TME Pharma | 12 |
| Aton | 9 |